You are here

Dr. Srivastava Receives Patent on New Chemical Process

Top Stories

Celebration to mark UL Lafayette’s prestigious Carnegie R1 designation

The University of Louisiana at Lafayette has taken its place in the top level of the nation’s research institutions

Read More ➝

Learn more about NIRC's BSL-3 Facility

The University of Louisiana at Lafayette broke ground last week on the expansion of its New Iberia Research Center,

Read More ➝

We are excited to announce the granting of a patent (US 9,394,229 B2) to Dr. Radhey Srivastava, Professor of Chemistry, and his colleague Siva Murra for new method to produce specific forms of chemicals. Their method reduces the time to produce the chemicals and cost of production by using copper instead of more expensive metals like palladium and iridium. With this method, copper compounds can be used as catalysts to create asymmetric chemicals important for health, such as the epilepsy drug Vigabatrin, the cholesterol lowering drug Ezetimibe, the Alzheimers drug Rivastigmine, the antifungal drug Naftifine, and the anti-depression drug Sertraline. These are just a few. There are over 20,000 useful bioactive molecules that can be created with this method, which also has the potential to impact the production of agrochemicals. Please join us in extending our congratulations to Dr. Srivastava!

We're here to help you manage the intellectual property rights of all your research discoveries made in conjunction with the University. We monitor new, innovative ideas developing in every department across the UL Lafayette campus, secure the appropriate protections for inventions (patents, trademarks, copyrights, etc.), and accelerate the movement of products from the lab to the marketplace.  Contact Innovation Management if you have any questions regarding intellectual property rights conceived here at the University.